It is recommended that cancer patients undergo a baseline audiogram before starting treatment with known ototoxic agents. Follow-up audiograms should be conducted regularly during and after treatment to monitor any changes in hearing ability. This proactive approach allows for timely intervention, potentially minimizing long-term hearing damage.
